Stay up-to-date in pulmonary and critical care. No spam.
The IASLC, ATS, and ERS got together to better incorporate clinical logic into classification of NSCLC. No more bronchioloalveolar carcinoma (they propose adenocarcinoma in situ or invasive mucinous adenocarcinoma, depending on its size). Large cell carcinoma with neuroendocrine features gets separated out of NSCLC entirely, so it can be treated as small cell. And so on. Giuseppe's digest is easier digested than the whole document. J Thorac Oncol 2011;6:244-285.